Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
69
GS Quote, Financials, Valuation and Earnings
Last price:
$547.13
Seasonality move
:
2.1%
Day range:
$541.30 - $550.88
52-week range:
$425.19 - $672.19
Dividend yield:
2.14%
P/E ratio:
12.74x
P/S ratio:
3.33x
P/B ratio:
1.38x
Volume:
1.7M
Avg. volume:
3.2M
1-year change:
27.42%
Market cap:
$170.6B
Revenue:
$53.5B
EPS (TTM):
$43.09
Analysts' Opinion
-
Consensus RatingThe Goldman Sachs Group has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 15 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $585.21, The Goldman Sachs Group has an estimated upside of 6.61% from its current price of $548.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $490.00 representing 10.73% downside risk from its current price of $548.92.
Fair Value
-
According to the consensus of 20 analysts, The Goldman Sachs Group has 6.61% upside to fair value with a price target of $585.21 per share.
GS vs. S&P 500
-
Over the past 5 trading days, The Goldman Sachs Group has overperformed the S&P 500 by 4.12% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Goldman Sachs Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Goldman Sachs Group has grown year-over-year revenues for 6 quarters straight. In the most recent quarter The Goldman Sachs Group reported revenues of $15.1B.
Earnings Growth
-
The Goldman Sachs Group has grown year-over-year earnings for 6 quarters straight. In the most recent quarter The Goldman Sachs Group reported earnings per share of $14.12.
Enterprise value:
337.6B
EV / Invested capital:
0.74x
Price / LTM sales:
3.33x
EV / EBIT:
3.72x
EV / Revenue:
6.21x
PEG ratio (5yr expected):
0.19x
EV / Free cash flow:
-22.06x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.87%
Net Income Margin (TTM):
27.38%
Return On Equity:
12.3%
Return On Invested Capital:
3.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $46.7B | $48.2B | $54.4B | $14.2B | $15.1B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $28.09 | $25.61 | $43.09 | $11.58 | $14.12 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $580.2B | $804.8B | $662B | $686.2B | $730B | |
| Total Assets | $1.3T | $1.6T | $1.5T | $1.7T | $1.8T | |
| Current Liabilities | $441B | $535.9B | $550.6B | $624.1B | $655B | |
| Total Liabilities | $1.2T | $1.5T | $1.4T | $1.6T | $1.6T | |
| Total Equity | $97.7B | $115.2B | $117.5B | $118.5B | $124B | |
| Total Debt | $305.2B | $335B | $323.9B | $327.6B | $334B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.7B | -$12.6B | -$13.2B | -$28.4B | $46.8B | |
| Cash From Investing | -$76B | -$17.3B | -$49.6B | -$3.3B | -$7.1B | |
| Cash From Financing | $59.6B | $27.8B | $7.3B | $28B | -$7.8B | |
| Free Cash Flow | $5B | -$14.9B | -$15.3B | -$28.9B | $46.2B | |
GS
Sector
Market Cap
$170.6B
$603.7M
Price % of 52-Week High
81.66%
84.45%
Dividend Yield
2.14%
2.05%
Shareholder Yield
6.51%
3.98%
1-Year Price Total Return
27.42%
9.07%
Beta (5-Year)
1.331
0.555
Dividend yield:
2.14%
Annualized payout:
$11.50
Payout ratio:
22.67%
Growth streak:
13 years
Technicals
8-day SMA
Buy
Level
$530.71
200-day SMA
Buy
Level
$546.86
Bollinger Bands (100)
Sell
Level
532.29 - 629.13
Chaikin Money Flow
Buy
Level
686.5M
20-day SMA
Buy
Level
$513.95
Relative Strength Index (RSI14)
Buy
Level
55.75
ADX Line
Buy
Level
20.66
Williams %R
Sell
Level
-5.196
50-day SMA
Sell
Level
$557.53
MACD (12, 26)
Sell
Level
-2.71
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-269.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4116)
Sell
CA Score
(Annual)
Level (-2.169)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (0.0423)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset & wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.
Stock Forecast FAQ
In the current month, GS has received 5 Buy ratings 15 Hold ratings, and 0 Sell ratings. The GS average analyst price target in the past 3 months is $585.21.
-
Where Will The Goldman Sachs Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Goldman Sachs Group share price will rise to $585.21 per share over the next 12 months.
-
What Do Analysts Say About The Goldman Sachs Group?
Analysts are divided on their view about The Goldman Sachs Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Goldman Sachs Group is a Sell and believe this share price will drop from its current level to $490.00.
-
What Is The Goldman Sachs Group's Price Target?
The price target for The Goldman Sachs Group over the next 1-year time period is forecast to be $585.21 according to 20 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 15 analysts rate the stock a Hold.
-
Is GS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Goldman Sachs Group is a Hold. 15 of 20 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GS?
You can purchase shares of The Goldman Sachs Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Goldman Sachs Group shares.
-
What Is The The Goldman Sachs Group Share Price Today?
The Goldman Sachs Group was last trading at $547.13 per share. This represents the most recent stock quote for The Goldman Sachs Group. Yesterday, The Goldman Sachs Group closed at $548.92 per share.
-
How To Buy The Goldman Sachs Group Stock Online?
In order to purchase The Goldman Sachs Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
